2020
DOI: 10.1016/j.jneuroim.2020.577171
|View full text |Cite
|
Sign up to set email alerts
|

Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis

Abstract: A B S T R A C TDistinguishing neurosarcoidosis (NS) from multiple sclerosis (MS) remains challenging and available parameters lack discriminatory power. Comprehensive flow cytometry data of blood and CSF leukocytes of patients with NS (n = 24), MS (n = 49) and idiopathic intracranial hypertension (IIH, n = 52) were analyzed by machine learning algorithms. NS featured a specific immune cell pattern with increased activated CD4+ T cells in CSF and increased plasma cells in blood. Combining blood and CSF paramete… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(15 citation statements)
references
References 39 publications
0
15
0
Order By: Relevance
“…Flow cytometry (fluorescence-activated cell sorting analysis) is an advanced method suitable for use in the CSF or PB in autoimmune brain diseases such as multiple sclerosis (MS), and it might also be well-suited for unraveling the immune mechanisms underlying a suspected LE [13,25,26]. Based on the evidence gathered from the preliminary findings first obtained from a few GAD65 antibody-positive patients [50,51] and then later on in a larger series [16,17], we hypothesized that T-and B-lymphocytes could serve as additional potential biomarkers in LE, and thereby help clarify the variance in otherwise unexplained neurocognitive symptoms.…”
Section: Introductionmentioning
confidence: 99%
“…Flow cytometry (fluorescence-activated cell sorting analysis) is an advanced method suitable for use in the CSF or PB in autoimmune brain diseases such as multiple sclerosis (MS), and it might also be well-suited for unraveling the immune mechanisms underlying a suspected LE [13,25,26]. Based on the evidence gathered from the preliminary findings first obtained from a few GAD65 antibody-positive patients [50,51] and then later on in a larger series [16,17], we hypothesized that T-and B-lymphocytes could serve as additional potential biomarkers in LE, and thereby help clarify the variance in otherwise unexplained neurocognitive symptoms.…”
Section: Introductionmentioning
confidence: 99%
“… 43 CSF CD4 + T-cell counts in multiple sclerosis were significantly higher than those of NID controls in this study (median in multiple sclerosis and NID controls 298.9 cells/ml and 81.6 cells/ml, respectively; P = 1.4 × 10 −6 ) and this is consistent with published data. 44 Whilst increased blood–brain- or blood–CSF-barrier permeability in multiple sclerosis is likely to be contributory, increased CD4 + T-cell proliferation could also be relevant. Indeed, differences in activation responses and clonal expansion of CD4 + T-cells has been implicated in multiple sclerosis pathogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…In neurosarcoidosis, an increased CD4/CD8 T cell ratio in CSF (>5.0) has been intensely investigated as a surrogate marker, aiding in differential diagnosis for many years with inconclusive results. Of clinical relevance, however, may be recent findings reporting (i) a negative predictive value of 88%, if a CD4/CD8 T cell ratio <5.0 is combined with an absence of pleocytosis [ 58 ], (ii) that IL-6 elevations of >50 pg/mL combined with an increased CD4/CD8 T cell ratio indicate relapse in active neurosarcoidosis [ 59 ], and (iii) that activated CD4 T cells in CSF combined with plasma cells in blood differentiate neurosarcoidosis from MS [ 60 ].…”
Section: Clinical Relevance Of Immune Phenotyping Of Csf Cells By Flow Cytometrymentioning
confidence: 99%